India’s low spending on childcare products and services, high birth rate compared to China and the United States, increasing maternity age,...

The announcement comes a day after Sanofi Healthcare India announced a separate partnership with Cipla to boost access to Sanofi's central ...

Covid-19 hasn't been good for cancer research as all the focus was on the pandemic. Despite important learnings from Covid-19 on immunother...

Under the terms of the agreement, Sentynl will acquire global rights to Nulibry and will be responsible for the ongoing development and com...

Healthtech platform Cloudphysician will use the funding to expand its global footprint and invest in strengthening its teams across vertica...

Sales of the nasal spray continue to progress well in Australia, South Africa, Ukraine and Uzbekistan, it said adding the company has also ...

On Thursday, Biocon had said it will offer around 15 per cent stake to Serum Institute Life Sciences at a post-money valuation of about Rs3...

Kejriwal announced the setting up of a paediatric task force and two genome sequencing labs as well as a plan to ramp up oxygen capacity to...

According to one of India’s best virologists, Dr Ravi from Nimhans Bengaluru, the third wave is likely to attack children, since most adult...

Sanofi, which acquired Shantha Bio in September 2009, said it spent over Rs 1,000 crore ($125 million) to expand production capacities, man...

Dhathri Group aims to double its turnover to Rs 200 crore in the current fiscal.

It is a capital-intensive business where companies require upfront payments to fund R&D activities, says Dr Rajesh Jain, joint managing dir...

After facing a regulatory clampdown by the US FDA in 2009, Caraco has had its manufacturing suspended. It now sells distributed products.

In order to offer Indian curriculum as prescribed by the CBSE, the foundation stone for a International Indian High School (IIHS) has been ...

Drug maker Lupin plans to acquire a speciality pharmaceutical company in the United States to expand its portfolio of brands in the paediat...

India may be a possible location as a global manufacturing base for vaccines business of Sanofi-Aventis Group.

The buzz about Reliance Anil Dhirubhai Ambani group (ADAG)’s shopping spree is about Max Healthcare.